Schonfeld Strategic Advisors’s MacroGenics MGNX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$115K	Buy	+39,917	New	+$85.1K	﹤0.01%	1861
2025 Q1	–	Sell	-857,505	Closed	-$2.79M	–	2383
2024 Q4	$2.79M	Buy	+857,505	New	+$3.09M	0.02%	708
2024 Q3	–	Sell	-122,782	Closed	-$522K	–	2259
2024 Q2	$522K	Buy	+122,782	New	+$1.2M	﹤0.01%	1464
2024 Q1	–	Sell	-76,246	Closed	-$733K	–	2274
2023 Q4	$733K	Buy	+76,246	New	+$527K	﹤0.01%	1149
2022 Q4	–	Sell	-62,600	Closed	-$216K	–	2852
2022 Q3	$216K	Sell	62,600 -46,800	-43%	-$179K	﹤0.01%	2293
2022 Q2	$323K	Buy	+109,400	New	+$575K	﹤0.01%	1627

Other funds holding MGNX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Schonfeld Strategic Advisors's MGNX Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in MacroGenics (MGNX) in Q1 2026: 39,917 shares worth $115K. The stake represents ﹤0.01% of the portfolio and ranks #1861 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in MGNX as recently as Q4 2024.

Schonfeld Strategic Advisors first reported a position in MGNX in Q2 2022 and has held it in 6 quarters since. The position peaked at $2.79M in Q4 2024. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

Schonfeld Strategic Advisors held 39,917 shares of MacroGenics worth $115K as of Q1 2026.
MacroGenics was a new Schonfeld Strategic Advisors position in Q1 2026.
MacroGenics made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1861 holding.
Schonfeld Strategic Advisors first reported a position in MacroGenics in Q2 2022 and has held it in 6 quarters since.
Schonfeld Strategic Advisors's MacroGenics position peaked at $2.79M in Q4 2024.
109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.